CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: To investigate the molecular effects of the double treatment, RNA-seq was performed on FACS-sorted hCD45+ CML cells isolated from the bone marrow of PDX mice bearing CD34+ PTPN11-mutated CML cells and treated as described above.